[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-371811-105":59,"doc-detail-371811-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","inhibitor-of-dna-binding-1-is-a-key-regulator-of-cancer-cell-vasculogenic-mimicry","Inhibitor of DNA binding-1 is a key regulator of cancer cell vasculogenic mimicry","","Solid tumours obtain blood supply through endothelial-dependent angiogenesis, but cancer cells can also generate vessel-like structures via vasculogenic mimicry (VM). Gene-expression profiling during early VM formation in MDA-MB-231-LM2 breast cancer cells identified inhibitor of DNA binding 1 (ID1) as strongly elevated within 2 hours. ID1 knockdown or chemical inhibition disrupted VM formation in breast and pancreatic cancer cells, reducing endothelial gene expression and pro-angiogenic protein production. ID1 expression increased in metastasis-associated cancer cells in vivo and its knockdown impaired tumour growth and metastasis, linking ID1 to a cancer cell vascular program supporting progression.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/inhibitor-of-dna-binding-1-is-a-key-regulator-of-cancer-cell-vasculogenic-mimicry/371811/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/inhibitor-of-dna-binding-1-is-a-key-regulator-of-cancer-cell-vasculogenic-mimicry/371811.png","ImageObject",300,407,{"name":92,"@type":93},"Jasmine","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-04","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":52},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What role does ID1 play in vasculogenic mimicry (VM)?","Question",{"text":112,"@type":113},"ID1 becomes markedly elevated during early VM formation and supports VM development in cancer cells. Disrupting ID1—by genetic knockdown or chemical inhibition—interrupts VM formation.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How did the study assess the impact of ID1 on VM-related signalling?",{"text":117,"@type":113},"Lowering ID1 reduced cancer cell expression of endothelial-associated genes and decreased production of pro-angiogenic proteins such as VEGF and IL-8.",{"name":119,"@type":110,"acceptedAnswer":120},"What in vivo evidence supports ID1 involvement in cancer progression and metastasis?",{"text":121,"@type":113},"In silico analysis showed higher ID1 expression in cancer cells metastasised to lungs or liver, along with enrichment of pro-angiogenic genes. Additionally, ID1 knockdown in a murine breast cancer model reduced tumour growth and metastasis in vivo.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},371811,1790523690,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":52,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":46,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":31,"preview_page_count":19,"preview_urls":144},2336478487870,"https://ap-avatar.wpscdn.com/davatar_085a072bc5b1113ac321206ff7593b45","Inhibitor of DNA binding-1 is a key regulator of cancer cell vasculogenic mimicry  \nEmma J. Thompson 1 , Emma L. Dorward 1, Kristyn Jurrius 1, Nathalie Nataren 1, Markus Tondl 1, Kay K. Myo Min 1, Michaelia P. Cockshell 1, Anahita Fouladzadeh 1, John Toubia 1,2, Mark DeNichilo 1, Delphine Merino3,4,5,6 and Claudine S. Bonder 1,7   \n1 Centre for Cancer Biology, University of South Australia and SA Pathology, Adelaide, Australia  \n2 ACRF Cancer Genomics Facility, Centre for Cancer Biology, University of South Australia and SA Pathology, Adelaide, Australia  \n3 Olivia Newton John Cancer Research Institute, Melbourne, Australia  \n4 School of Cancer Medicine, La Trobe University, Bundoora, Australia  \n5 Department of Medical Biology, The Faculty of Medicine, Dentistry and Health Science, The University of Melbourne, Australia  \n6 Immunology Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, Australia  \n7 Adelaide Medical School, University of Adelaide, Australia  \nKeywords  \nbreast cancer; ID1; pancreatic cancer; tumour vasculature; vasculogenic mimicry  \nCorrespondence  \nC. S. Bonder, Centre for Cancer Biology, University of South Australia and SA Pathology, Bradley Building, North Terrace, Adelaide, SA 5000, Australia  \nE-mail: [claudine.bonder@unisa.edu.au](claudine.bonder@unisa.edu.au)  \n(Received 15 April 2024, revised 12  \nDecember 2024, accepted 14 March 2025, available online 21 March 2025)  \ndoi:10 . 1002/1878-0261 .70027  \nSolid tumours routinely access the blood supply by promoting endothelium-dependent angiogenesis; but tumour vasculature can also be formed by cancer cells themselves via vasculogenic mimicry (VM) . Investigation of the gene expression proﬁle during the early stages of VM formation by MDA-MB-231-LM2 breast cancer cells identiﬁed the transcriptional regulator inhibitor of DNA binding 1 (ID1) to be elevated~ 10-fold within the ﬁrst 2 hours. This role for ID1 in promoting VM was supported by ID1 genetic knockdown or chemical inhibition interrupting VM formation by MDA-MB-231-LM2 (breast) and BxPC-3 (pancreatic) cancer cells. More speciﬁcally, reducing ID1 lowered cancer cell expression of endothelial cell genes (e.g. CDH5, TIE2) and production of pro-angiogenic proteins (e.g. VEGF, CD31, MMP9 and IL-8) . In silico analysis of MDA-MB-231 cells engrafted into mice identiﬁed elevated ID1 expression in cancer cells that had metastasised to the lungs or liver, and an enrichment of pro-angiogenic genes. Additionally, Id1 knockdown in 4T1.13 murine breast cancer cells demonstrated reduced tumour growth and metastasis in vivo. Taken together, this study further implicates ID1 ina vascular program within cancer cells that supports disease progression.  \nAbbreviations  \n2D, 2-dimensional; 3D, 3-dimensional; BSA, bovine serum albumin; CPM, counts per million; CYCA, cyclophilin A; DGE, differential gene expression; DKK1, Dickkopf-1; DMEM, Dulbecco’s modiﬁed Eagle medium; DMSO, dimethylsulphoxide; EC, endothelial cell; ECGS, endothelial cell growth supplement; ECM, extracellular matrix; EMMPRIN, extracellular matrix metalloproteinase inducer; EMT, epithelialto-mesenchymal transition; FBS, fetal bovine serum; GAPDH, glyceraldehyde-3-phosphate dehydrogenase; GO, gene ontology; HLH, helix–loop–helix; HUVE, human umbilical vein endothelial; ID1, inhibitor of DNA binding; IHC, immunohistochemistry; IL, interleukin; LeGO, lentiviral gene ontology; LucGFP, luciferase green ﬂuorescent protein; mAb, monoclonal antibody; MES, 2-(N-morpholino)ethanesulfonic acid; miRNA, micro ribonucleic acid; MMP, matrix metalloprotease; NSG, NOD scid gamma; PAI-1, plasminogen activator inhibitor-1; PAS, periodic acid schiff; PBS, phosphate buffered saline; PDAC, pancreatic ductal adenocarcinoma; PDGF, platelet-derived growth factor; RPMI, Roswell Park Memorial Institute; siRNA, small interfering ribonucleic acid; STAR, Spliced Transcripts Alignment to a Reference; TCP, tissue culture plastic; TMM, trimmed mean of M-val","cbCaiv7dnJXJTW8L","https://ap.wps.com/l/cbCaiv7dnJXJTW8L","pdf",5367371,"English","# Introduction\n## Cancer and tumour vascularisation\n## Measuring vasculogenic mimicry\n## Study rationale and knowledge gap","[{\"question\":\"What role does ID1 play in vasculogenic mimicry (VM)?\",\"answer\":\"ID1 becomes markedly elevated during early VM formation and supports VM development in cancer cells. Disrupting ID1—by genetic knockdown or chemical inhibition—interrupts VM formation.\"},{\"question\":\"How did the study assess the impact of ID1 on VM-related signalling?\",\"answer\":\"Lowering ID1 reduced cancer cell expression of endothelial-associated genes and decreased production of pro-angiogenic proteins such as VEGF and IL-8.\"},{\"question\":\"What in vivo evidence supports ID1 involvement in cancer progression and metastasis?\",\"answer\":\"In silico analysis showed higher ID1 expression in cancer cells metastasised to lungs or liver, along with enrichment of pro-angiogenic genes. Additionally, ID1 knockdown in a murine breast cancer model reduced tumour growth and metastasis in vivo.\"}]","Inhibitor of DNA binding-1 is a key regulator of cancer cell vasculogenic mimicry | PDF",1790192923,[145,149,153,157],{"page_no":8,"url":146,"width":147,"height":148},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/19e3f43cd10cfe0b84d67c0b4a7f73f0.webp",983,1291,{"page_no":14,"url":150,"width":151,"height":152},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2a0827283972001a2f3d5f645bbf3b7e.webp",982,1290,{"page_no":81,"url":154,"width":155,"height":156},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d873de4c16b640707e6b753e54a1dbeb.webp",981,1289,{"page_no":19,"url":158,"width":159,"height":160},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/21886d83ffb3e3c9655d287b0e817c6b.webp",980,1287]